Login / Signup

[Subthreshold micropulse laser treatment of the foveal region in chronic central serous chorioretinopathy (case study)].

V A ShaimovaV N TrubilinT B ShaimovG R IslamovaR B ShaimovS Kh KuchkildinaA A AskaevaA V Fomin
Published in: Vestnik oftalmologii (2023)
The article presents a clinical case of subthreshold micropulse laser (SML) treatment of chronic central serous chorioretinopathy (CSC) in the left eye of a 44-year-old female patient K . with dye allergy. The patient first noticed a gray spot, distortion of objects in February, 2018. During 2018-2020 she suffered 5 relapses, repeated unsuccessful conservative treatment, and completed a course of antiangiogenic therapy in the form of three monthly intravitreal injections of ranibizumab. After experiencing stress on 11.08.20 she noted acute deterioration. Laser treatment was carried out on 20.09.20 with the Navilas 577s navigation system (wavelength 577 nm). After the power titration and calculation, the contact-free subthreshold micropulse laser treatment was carried out without anesthesia in three zones: 200 mW for fovea, 240 mW for parafovea and 340 mW for periphovea. Other settings: pulse duration - 200 ms, spot diameter - 100 µm, duty cycle - 5%. Total number of laser pulses - 1000. The retina reattached completely despite the patient having previously recovered from the coronavirus infection and the use of corticosteroids.
Keyphrases
  • blood pressure
  • multiple sclerosis
  • mass spectrometry
  • sars cov
  • diabetic retinopathy
  • bone marrow
  • coronavirus disease
  • atopic dermatitis